-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Ascentage Pharma Group, Lowers Price Target to $33

Benzinga·10/08/2026 21:00:02
Listen to the news
JP Morgan analyst Brian Cheng maintains Ascentage Pharma Group (NASDAQ:AAPG) with a Overweight and lowers the price target from $46 to $33.